Try Fund Library Premium

For Free with a 30 day trial!

Gain access to

  • Unlimited Watchlists
  • Advanced Search Filtering
  • Fund Comparisons
  • Portfolio Scenarios
  • Customizable PDF Reports

TD Health Sciences Fund - F Series US$

Health Care Equity

FundGrade C Click for more information on Fundata’s FundGrade

FundGrade C

Click for more information on Fundata’s FundGrade.

Fundata ESG GradeC Click for more information on Fundata’s ESG Grade

Fundata ESG Grade C

Click for more information on Fundata’s ESG Grade.

NAVPS
(05-01-2025)
$53.65
Change
-$1.33 (-2.42%)

As at March 31, 2025

As at March 31, 2025

As at March 31, 2025

Period
Created with Highcharts 10.3.3Jan 2019Jul 2019Jan 2020Jul 2020Jan 2021Jul 2021Jan 2022Jul 2022Jan 2023Jul 2023Jan 2024Jul 2024Jan 2025Apr 2022Oct 2022Apr 2023Oct 2023Apr 2024Oct 2024Jan 2019Jan 2020Jan 2021Jan 2022Jan 2023Jan 2024Jan 2025Jan 2…$10,000$7,500$12,500$15,000$17,500$8,000$9,000$11,000$12,000Period

Legend

TD Health Sciences Fund - F Series US$

Compare Options


Fund Returns

Inception Return (August 16, 2018): 6.09%

Fund Returns
Row Heading Return Annualized Return
1 Mth 3 Mth 6 Mth YTD 1 Yr 2 Yr 3 Yr 4 Yr 5 Yr 6 Yr 7 Yr 8 Yr 9 Yr 10 Yr
Fund -4.19% -0.16% -11.19% -0.16% -6.42% 2.95% -0.39% 0.35% 8.44% 6.28% - - - -
Benchmark -2.39% 4.35% -7.28% 4.35% -1.04% 5.53% 1.93% 3.78% 8.86% 7.32% 7.94% 8.53% 8.57% 6.87%
Category Average - - - - - - - - - - - - - -
Category Rank - - - - - - - - - - - - - -
Quartile Ranking - - - - - - - - - - - - - -

Monthly Return

Created with Highcharts 10.3.3-10%-5%0%5%10%
Monthly Return
Return % Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar
Fund -5.06% 2.25% 2.76% 2.67% 4.96% -1.99% -5.03% 1.41% -7.63% 6.18% -1.86% -4.19%
Benchmark -3.91% 2.44% 1.78% 3.52% 5.37% -2.34% -4.88% -0.84% -5.79% 5.96% 0.89% -2.39%

Best Monthly Return Since Inception

13.99% (April 2020)

Worst Monthly Return Since Inception

-12.53% (January 2022)

Calendar Return (%)

Created with Highcharts 10.3.3-20%-10%0%10%20%30%40%
Calendar Return
Return % 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fund - - - - 28.44% 28.46% 11.75% -12.84% 2.53% 1.01%
Benchmark 7.23% -5.90% 22.06% 2.83% 22.96% 15.87% 15.77% -8.00% 3.85% 1.06%
Category Average - - - - - - - - - -
Quartile Ranking - - - - - - - - - -
Category Rank - - - - - - - - - -

Best Calendar Return (Last 10 years)

28.46% (2020)

Worst Calendar Return (Last 10 years)

-12.84% (2022)

Asset Allocation

Asset Allocation
Name Percent
US Equity 84.40
International Equity 15.03
Foreign Corporate Bonds 0.55
Cash and Equivalents 0.01
Other 0.01

Sector Allocation

Sector Allocation
Name Percent
Healthcare 93.40
Consumer Services 0.98
Fixed Income 0.55
Financial Services 0.26
Industrial Goods 0.16
Other 4.65

Geographic Allocation

Geographic Allocation
Name Percent
North America 84.97
Europe 12.20
Asia 2.80
Africa and Middle East 0.04
Other -0.01

Top Holdings

Top Holdings
Name Percent
Eli Lilly and Co 10.81
UnitedHealth Group Inc 7.17
Intuitive Surgical Inc 4.99
Stryker Corp 4.51
Thermo Fisher Scientific Inc 3.97
argenx SE - ADR 3.58
Vertex Pharmaceuticals Inc 3.30
Boston Scientific Corp 3.16
Danaher Corp 3.10
Alnylam Pharmaceuticals Inc 2.53

Equity Style

Market capitalization is large. Equity style is growth.

Fixed Income Style

Fixed income style data not available
Period: 

Risk vs Return (3 Yr)

Created with Highcharts 10.3.3Risk (Annualized Standard Deviation)ReturnMedian DeviationMedian Return101112131415161718192021-10%-5%0%5%10%15%

TD Health Sciences Fund - F Series US$

Median

Other - Health Care Equity

3 Yr Annualized

Standard Deviation 14.62% 16.31% -
Beta 1.23% 1.24% -
Alpha -0.08% -0.02% -
Rsquared 0.76% 0.77% -
Sharpe -0.22% 0.43% -
Sortino -0.22% 0.60% -
Treynor -0.03% 0.06% -
Tax Efficiency - 100.00% -
Volatility Volatility rating is 8 on a scale of 1 to 10 Volatility rating is 9 on a scale of 1 to 10 -

Risk Rating

Rating 8 out of ten

Annualized Key Ratio Period Comparison

Key Ratio
Key Ratio 1 Yr 3 Yr 5 Yr 10 Yr
Standard Deviation 15.36% 14.62% 16.31% -
Beta 1.27% 1.23% 1.24% -
Alpha -0.12% -0.08% -0.02% -
Rsquared 0.84% 0.76% 0.77% -
Sharpe -0.61% -0.22% 0.43% -
Sortino -0.70% -0.22% 0.60% -
Treynor -0.07% -0.03% 0.06% -
Tax Efficiency - - 100.00% -

Fundata ESG Metrics

Fundata ESG Score

Created with Highcharts 10.3.3Grade: EGrade: DGrade: CGrade: BGrade: A41.441.476.576.50%10%20%30%40%50%60%70%80%90%100%

The E, S, and G scores are averaged for each security in the portfolio, to arrive at an ESG score for each security. We take the portfolio weighted average of the ESG scores for each fund and rank them against their peers to arrive at the Fundata ESG Score from 0-100.

Fundata E Score

Created with Highcharts 10.3.3Grade: EGrade: DGrade: CGrade: BGrade: A38.538.576.076.00%10%20%30%40%50%60%70%80%90%100%

Three scores under the Environment bucket are averaged to yield the Fundata Environment Score for each fund from 0-100: (1) Pollution Prevention, (2) Environmental Transparency, (3) Resource Efficiency.

Fundata S Score

Created with Highcharts 10.3.3Grade: EGrade: DGrade: CGrade: BGrade: A48.648.678.478.40%10%20%30%40%50%60%70%80%90%100%

Six scores under the Social bucket are averaged to yield the Fundata Social Score for each fund from 0-100. (1) Compensation and Satisfaction, (2) Diversity and Rights, (3) Education and Work Conditions, (4) Community and Charity, (5) Human Rights, (6) Sustainability Integration.

Fundata G Score

Created with Highcharts 10.3.3Grade: EGrade: DGrade: CGrade: BGrade: A47.347.374.974.90%10%20%30%40%50%60%70%80%90%100%

Three scores under the governance bucket are averaged to yield the Fundata Governance Score for each fund from 0-100: (1) Board Effectiveness, (2) Management Ethics, (3) Disclosure and Accountability.

Powered by OWL Analytics. For more information, please contact Fundata Canada.

Fund Details

Start Date August 16, 2018
Instrument Type Mutual Fund
Share Class Fee Based Advice
Legal Status Trust
Sales Status Open
Currency USD
Distribution Frequency Annual
Assets ($mil) $1,024

Fund Codes

FundServ Code Load Code Sales Status
TDB3515

Investment Objectives

The fundamental investment objective of the Fund is to achieve long-term capital appreciation by investing primarily in equity securities of companies located in the United States and other countries, that are engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences.

Investment Strategy

The sub-adviser seeks to achieve the fundamental investment objective of the Fund by investing at least 65% of the Fund’s total assets in common stocks of companies in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences. The sub-adviser divides the health sciences sector into four main areas: pharmaceuticals, health care services, products and devices, and biotechnology firms.

Portfolio Management

Portfolio Manager

TD Asset Management Inc.

Sub-Advisor

T. Rowe Price Associates, Inc.

  • Ziad Bakri

Management and Organization

Fund Manager

TD Asset Management Inc.

Custodian

CIBC Mellon Trust Company

Registrar

The Toronto-Dominion Bank

Distributor

TD Investment Services Inc

Investment Minimums

RSP Eligible Yes
PAC Allowed Yes
PAC Initial Investment -
PAC Subsequent -
SWP Allowed Yes
SWP Min Balance -
SWP Min Withdrawal -

Fees

MER 1.39%
Management Fee 1.25%
Load No Load
FE Max -
DSC Max -
Trailer Fee Max (FE) -
Trailer Fee Max (DSC) -
Trailer Fee Max (NL) 0.00%
Trailer Fee Max (LL) -

Try Fund Library Premium

For Free with a 30 day trial!

Gain access to

  • Unlimited Watchlists
  • Advanced Search Filtering
  • Fund Comparisons
  • Portfolio Scenarios
  • Customizable PDF Reports